These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 378647)

  • 1. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and effects of sedatives and analgesics in liver disease.
    Hoyampa AM; Branch RA; Schenker S
    Annu Rev Med; 1978; 29():205-18. PubMed ID: 348033
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of liver diseases on drug disposition.
    Roberts RK; Branch RA; Desmond PV; Schenker S
    Clin Gastroenterol; 1979 Jan; 8(1):105-21. PubMed ID: 369741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
    Schenker S; Hoyumpa AM; Wilkinson GR
    Med Clin North Am; 1975 Jul; 59(4):887-96. PubMed ID: 238085
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism in patients with liver disease.
    Secor JW; Schenker S
    Adv Intern Med; 1987; 32():379-405. PubMed ID: 3548257
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug kinetics in childbirth.
    Nation RL
    Clin Pharmacokinet; 1980; 5(4):340-64. PubMed ID: 6994980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ethanol on drug and metabolite pharmacokinetics.
    Lane EA; Guthrie S; Linnoila M
    Clin Pharmacokinet; 1985; 10(3):228-47. PubMed ID: 2861929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for drug therapy in renal failure.
    Bennett WM; Singer I; Golper T; Feig P; Coggins CJ
    Ann Intern Med; 1977 Jun; 86(6):754-83. PubMed ID: 869359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal drug administration: clinical pharmacokinetic considerations.
    de Boer AG; Moolenaar F; de Leede LG; Breimer DD
    Clin Pharmacokinet; 1982; 7(4):285-311. PubMed ID: 6126289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic disease and drug pharmacokinetics.
    Williams RL; Mamelok RD
    Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transplacental passage of drugs].
    Sjöqvist F
    Nord Med; 1967 Oct; 78(42):1354-8. PubMed ID: 4385511
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein binding and kinetics of drugs in liver diseases.
    Blaschke TF
    Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of drugs in pregnancy.
    Mucklow JC
    Clin Obstet Gynaecol; 1986 Jun; 13(2):161-75. PubMed ID: 2873913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].
    Becker K
    Z Gastroenterol; 1977 Jun; 15(6):356-61. PubMed ID: 888484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food and hepatobiliary disease on the excretion of josamycin.
    Bergan T; Tolås P; Oydvin B
    Pharmacology; 1972; 8(4):336-43. PubMed ID: 4572010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.